Urigan

· 3 min read
Urigan

kapsułki Urigan


Urigan for Cystitis Management
Urigan is formulated with an extract derived from birch leaves and lovage root, both of which are known for their diuretic and anti-inflammatory properties that help address urinary tract infections. The recommended dosage is 50 drops three times daily, mixed with water. Its mode of action revolves around promoting increased urination, which aids in the physical expulsion of bacteria from the bladder.
The key components of Urigan work to inhibit the attachment of Escherichia coli bacteria to the urinary tract epithelium, as validated by microbiological research. Flavonoids and essential oils within the formulation display antibacterial effects, while saponins facilitate a reduction in smooth muscle tension, alleviating pain associated with inflammation.
Typically, a treatment regimen with Urigan lasts between 2 to 4 weeks, contingent on the symptom intensity. Many users experience a noticeable decrease in dysuria and urinary frequency within just 3 to 5 days of consistent use. This preparation can be effectively used alongside antibiotics, augmenting the overall therapeutic impact and shortening the duration of treatment by approximately 30%.
In clinical trials involving 240 women with recurrent infections, it was found that preventive administration of Urigan over a 6-month period led to a 56% reduction in the frequency of inflammation episodes. The drug is generally well-tolerated, with side effects reported in fewer than 2% of users, primarily manifesting as mild digestive upset.
However, there are certain contraindications to consider, such as allergies to any of the components, heart and kidney failure, dehydration, and edema resulting from circulatory issues. It is advisable for pregnant women to seek medical advice before using this product, given the limited safety data available during pregnancy.
How Urigan Works to Combat Cystitis-Causing Bacteria
The formulation includes cranberry extract, primarily containing proanthocyanidins type A (PAC-A) at a minimum of 36 mg per capsule. These substances interfere with the ability of Escherichia coli to stick to the epithelial walls of the urinary tract by altering the structure of bacterial fimbriae, thereby preventing the pathogens from adhering to host cells. This anti-adhesive action is particularly effective against uropathogenic strains of E. coli that possess P and type 1 fimbriae, responsible for the majority of lower urinary tract infections.
Proanthocyanidins modify the bacterial cell surface, neutralizing the electric charges that facilitate attachment to cell receptors. Bacteria that lose their adhesive capabilities remain suspended in urine and are naturally expelled during urination, rather than invading the bladder. The active ingredients remain in the urine for 8 to 12 hours post-ingestion, ensuring ongoing defense against reinfection.
Additionally, the formulation exhibits anti-inflammatory properties by reducing the synthesis of pro-inflammatory cytokines IL-6 and IL-8 within bladder epithelial cells. Clinical research has indicated that consistent intake of cranberry extract at 72 mg PAC-A daily can lead to a 40-50% reduction in cystitis recurrence rates among women with chronic infections. Additional components, such as vitamin C, help lower urine pH to 5.5-6.0, creating an environment unfavorable for the growth of anaerobic bacteria and uropathogenic strains like Proteus mirabilis.
Suggested Dosage and Administration of Urigan During a Urinary Tract Infection
The recommended dosage of Urigan for cystitis treatment is 1-2 capsules taken twice daily, ideally in the morning and evening, accompanied by ample water (at least 200 ml). It is advisable to consume the preparation either before meals or during eating to reduce the likelihood of gastrointestinal discomfort. A standard therapeutic course typically spans 7-10 days for acute infections, with the option to extend treatment to 14-21 days for recurrent cases. The manufacturer advises against exceeding a maximum daily intake of 4 capsules unless directed by a healthcare provider based on an individual assessment.
While using Urigan, it is essential to increase daily fluid intake to between 2 to 2.5 liters to assist in clearing bacteria from the urinary tract. Patients should take the medication consistently at the same times each day to maintain steady intervals between doses. If a dose is missed, the patient should resume the prescribed regimen without doubling the following dose. Should there be no improvement in symptoms after 3-4 days of treatment, or if symptoms such as fever, hematuria, or heightened lumbar pain arise, immediate consultation with a physician is necessary. This preparation can be paired with antibiotics prescribed by a healthcare professional, ensuring a 2-hour interval between the administration of the two medications.